nivolumab,ipilimumab
bms
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'niche-2']
interesting results from niche-2 presented at presidential sympo 95%pmr 67%pcr in dmmr crc after neoadj io combination!!
food for thoughts after all presentations &amp; discussions:does duration of exposure matter?is ctla4 key player?how to better select pts? 
Medical oncologist l @GustaveRoussy GU team l Former @AssoAERIO president l Also loving the Beatles ??& British music in general